trial · primary record
Ruxolitinib
Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2028-10-27 |
| Primary endpoint | incidence and severity of SAEs |
| Registry ID | NCT07913672 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:31.168Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07913672
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ruxolitinib · approval
- Ruxolitinib · compound